Publications

• Direct Optical Detection of Factor Xa Activity in Minimally Processed Whole Blood.
  ACS Sens Volume: 10 Page(s): 3143 - 3151
  04/25/2025 Authors: Cartwright AP; Wollant BC; York ES; Zheng L; Yee S; Chau HC; Batsuli G; Soh HT
• Persistent splenic-derived IgMs preferentially recognize factor VIII A2 and C2 domain epitopes but do not alter antibody production.
  J Thromb Haemost Volume: 23 Page(s): 440 - 457
  02/01/2025 Authors: York ES; Dratch BD; Ito J; Horwitz SM; Emamian S; Ambarian JA; Gill S; Jones J; Chonat S; Lollar P
• Real-world effectiveness of eptacog beta in patients with haemophilia and inhibitors: A multi-institutional case series.
  Haemophilia Volume: 30 Page(s): 1321 - 1331
  11/01/2024 Authors: Youkhana K; Batsuli G; Acharya S; Khan O; Tran DQ; Dvorak A; Recht M; Young G; Sidonio R; Abajas Y
• Assessment of menstrual health in adolescent and young adults with sickle cell disease.
  Pediatr Blood Cancer Volume: 71 Page(s): e30727
  01/01/2024 Authors: Notice B; Soffer E; Tickle K; Xiang Y; Gee BE; Sidonio RF; Sokkary N; Batsuli G
• Severe muscle bleeds in children and young adults with hemophilia A on emicizumab prophylaxis: Real-world retrospective multi-institutional cohort.
  Am J Hematol Volume: 98 Page(s): E285 - E287
  10/01/2023 Authors: Batsuli G; Wheeler AP; Weyand AC; Sidonio RF; Young G
• The impact of concurrent X chromosome anomalies on diagnosis and bleeding phenotype in children with hemophilia: A single-institution case series.
  Pediatr Blood Cancer Volume: 70 Page(s): e30400
  07/01/2023 Authors: Soffer E; Coleman K; Batsuli G
• Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: facilitating research through infrastructure, workforce, resources and funding.
  Expert Rev Hematol Volume: 16 Page(s): 107 - 127
  03/01/2023 Authors: Ragni MV; Young G; Batsuli G; Bisson E; Carpenter SL; Croteau SE; Cuker A; Curtis RG; Denne M; Ewenstein B
• Factor VIII antibody immune complexes modulate the humoral response to factor VIII in an epitope-dependent manner.
  Front Immunol Volume: 14 Page(s): 1233356
  01/01/2023 Authors: Batsuli G; Ito J; York ES; Cox C; Baldwin W; Gill S; Lollar P; Meeks SL
• A review of the pharmacokinetics, efficacy and safety of high-purity factor X for the prophylactic treatment of hereditary factor X deficiency.
  Haemophilia Volume: 28 Page(s): 523 - 531
  07/01/2022 Authors: Payne J; Batsuli G; Leavitt AD; Mathias M; McGuinn CE
• Iron deficiency anemia and bleeding management in pediatric patients with Bernard-Soulier syndrome and Glanzmann Thrombasthenia: A single-institution analysis.
  Haemophilia Volume: 28 Page(s): 633 - 641
  07/01/2022 Authors: Lee A; Maier CL; Batsuli G
• Removal of single-site N-linked glycans on factor VIII alters binding of domain-specific monoclonal antibodies.
  J Thromb Haemost Volume: 20 Page(s): 574 - 588
  03/01/2022 Authors: Ito J; Baldwin WH; Cox C; Healey JF; Parker ET; Legan ER; Li R; Gill S; Batsuli G
• Successful Perioperative Management of Orthotopic Cardiac Transplantation in a Pediatric Patient With Concurrent Congenital von Willebrand Disease and Acquired von Willebrand Syndrome Using Recombinant von Willebrand Factor.
  J Cardiothorac Vasc Anesth Volume: 36 Page(s): 724 - 727
  03/01/2022 Authors: Batsuli G; Zimowski KL; Carroll R; White MH; Woods GM; Meeks SL; Sidonio RF
• Reticular Dysgenesis: A Rare Immunodeficiency in a Neonate With Cytopenias and Bacterial Sepsis.
  Pediatrics Volume: 148
  12/01/2021 Authors: Janardan SK; Pencheva B; Ross A; Karpen HE; Rytting H; Batsuli G
• Rare Coagulation Factor Deficiencies (Factors VII, X, V, and II).
  Hematol Oncol Clin North Am Volume: 35 Page(s): 1181 - 1196
  12/01/2021 Authors: Batsuli G; Kouides P
• Plasma factor IX: The tip of the iceberg?
  Haemophilia Volume: 27 Page(s): 329 - 331
  05/01/2021 Authors: Sidonio RF; Batsuli G
• Emicizumab in tolerized patients with hemophilia A with inhibitors: A single-institution pediatric cohort assessing inhibitor status.
  Res Pract Thromb Haemost Volume: 5 Page(s): 342 - 348
  02/01/2021 Authors: Batsuli G; Greene A; Meeks SL; Sidonio RF
• Thrombocytosis with acquired von Willebrand disease in an adolescent with sickle cell disease.
  Clin Case Rep Volume: 9 Page(s): 457 - 460
  01/01/2021 Authors: Yee MEM; Batsuli G; Chonat S; Park S
• Use of plasma-derived factor X concentrate in neonates and infants with congenital factor X deficiency.
  J Thromb Haemost Volume: 18 Page(s): 2551 - 2556
  10/01/2020 Authors: Zimowski KL; McGuinn CE; Abajas YL; Schultz CL; Kaicker S; Batsuli G
• Inhibitor status of patients with Hemophilia A who transition to Emicizumab after Immune Tolerance Induction
  Volume: 26 Page(s): 28 - 28
  06/01/2020 Authors: Batsuli G; Greene A; Meeks SL; Sidonio RF
• THE IMPACT OF CONCURRENT X-CHROMOSOME ABNORMALITIES ON BLEEDING PHENOTYPE IN PEDIATRIC HEMOPHILIA
  Volume: 67 Page(s): S61 - S61
  06/01/2020 Authors: Soffer E; Coleman K; Meeks S; Batsuli G
• Epitope Dependent Augmentation of the Immune Response in Hemophilia. Mice Immunized with Factor VIII/Antibody Immune Complexes
  Volume: 134
  11/13/2019 Authors: Batsuli G; Patel SR; Cox C; Baldwin WH; Lollar JS; Meeks SL
• The Immune Response to Murine Factor VIII in Single Exon Deletion and Total Gene Deletion Murine Models of Hemophilia a
  Volume: 134
  11/13/2019 Authors: Patel SR; Baldwin WH; Cox C; Healey J; Parker ET; Batsuli G; Meeks SL
• Severe Bleeding Events in Hemophilia. Patients Receiving Emicizumab Prophylaxis
  Volume: 134
  11/13/2019 Authors: Zimowski KL; Batsuli GM; Bryant P; McDaniel J; Tickle K; Meeks SL; Sidonio RF
• Immune tolerance induction in paediatric patients with haemophilia A and inhibitors receiving emicizumab prophylaxis.
  Haemophilia Volume: 25 Page(s): 789 - 796
  09/01/2019 Authors: Batsuli G; Zimowski KL; Tickle K; Meeks SL; Sidonio RF
• Factor XIII, alpha(2)-Antiplasmin, and Plasminogen Activator Inhibitor-1 Deficiencies
  Page(s): 707 - 710
  01/01/2019 Authors: Batsuli G; Meeks SL
• Congenital Disorders of Fibrinogen
  Page(s): 703 - 706
  01/01/2019 Authors: Batsuli G; Meeks SL
• Maintaining Perioperative Hemostasis in Patients with Severe Hemophilia A and Inhibitors Receiving Emicizumab Prophylaxis
  Volume: 132
  11/29/2018 Authors: Zimowski KL; Batsuli GM; Reding MT; Rana J; Callaghan MU; Tickle K; Meeks SL; Sidonio RF
• Anti-C1 domain antibodies that accelerate factorVIII clearance contribute to antibody pathogenicity in a murine hemophiliaA model.
  J Thromb Haemost Volume: 16 Page(s): 1779 - 1788
  09/01/2018 Authors: Batsuli G; Ito J; Mercer R; Baldwin WH; Cox C; Parker ET; Healey JF; Lollar P; Meeks SL
• Long-term outcomes of patients with severe hemophilia A and high titer inhibitors with partial tolerance after immune tolerance induction
  Volume: 24 Page(s): 48 - 49
  05/01/2018 Authors: Batsuli G; Meeks S; Sidonio R
• The Impact of Specific Factor VIII Domains on Uptake By Dendritic Cells
  Volume: 130
  12/07/2017 Authors: Batsuli GM; Meeks SL; Lollar JS
• Very High Dose Factor VIII Needed to Prevent Bleeding in the Presence of a Low Titer Anti-C1 Domain Antibody
  Volume: 128
  12/02/2016 Authors: Ito J; Mercer R; Baldwin WH; Batsuli G; Meeks SL
• Factor VIII C2 Domain Epitopes Recognized By Classical and Non-Classical Anti-C2 Domain Monoclonal Antibodies Help Mediate FVIII Uptake By Dendritic Cells
  Volume: 128
  12/02/2016 Authors: Batsuli G; Baldwin WH; Healey JF; Parker ET; Cox C; Lollar P; Meeks SL
• Hemophilia and inhibitors: current treatment options and potential new therapeutic approaches.
  Hematology Am Soc Hematol Educ Program Volume: 2016 Page(s): 657 - 662
  12/02/2016 Authors: Meeks SL; Batsuli G
• High-affinity, noninhibitory pathogenic C1 domain antibodies are present in patients with hemophilia A and inhibitors.
  Blood Volume: 128 Page(s): 2055 - 2067
  10/20/2016 Authors: Batsuli G; Deng W; Healey JF; Parker ET; Baldwin WH; Cox C; Nguyen B; Kahle J; Knigs C; Li R
• Innovating immune tolerance induction for haemophilia.
  Haemophilia Volume: 22 Suppl 5 Page(s): 31 - 35
  07/01/2016 Authors: Batsuli G; Meeks SL; Herzog RW; Lacroix-Desmazes S
• Anti-C1 Domain Antibodies Are Pathogenic in a Murine Tail Snip Model Despite Low Inhibitor Titers
  Volume: 126
  12/03/2015 Authors: Batsuli G; Healey J; Parker E; Baldwin WH; Nguyen B; Lollar P; Meeks SL
• An Immunodominant B Cell Epitope is Present on the C1 Domain of FVIII
  HAEMOPHILIA Volume: 21 Page(s): E260 - E261
  05/01/2015 Authors: Batsuli G; Healey J; Baldwin W; Parker E; Lollar P; Meeks S
• Anti-Factor VIII C1 Domain Antibodies Are Present in the Plasmas of Patients with Hemophilia and Inhibitors
  Volume: 124
  12/06/2014 Authors: Batsuli G; Cox C; Healey JF; Lollar P; Meeks SL
• ROLE OF RACE/ETHNICITY ON IMMUNE TOLERANCE INDUCTION AND INHIBITOR RELAPSE IN CHILDREN WITH HEMOPHILIA A
  PEDIATRIC BLOOD & CANCER Volume: 58 Page(s): 1032 - 1032
  07/01/2012 Authors: Batsuli G; Chapman R; Cox C; Dunn A; Meeks S